Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

[What you need to know about the Moderna and Pfizer coronavirus vaccines] Researchers in the United States set an audacious goal in January last year to develop a coronavirus vaccine within 12 to ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

A group of researchers last week released a small, preliminary paper theorizing that Covid-19 vaccines ... received most of the vaccines used in the U.S. — Pfizer’s, Moderna’s, and a Johnson ...

A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine. Moderna, Inc. (NASDAQ ... is focusing on maintaining its COVID-19 vaccination market share in ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

March 5, 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on ...

(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.